SWS Medical(SH:688410) Xin Lang Cai Jing·2025-09-24 03:15Company Overview - The company, Chongqing Shanwaishan Blood Purification Technology Co., Ltd., was established on March 26, 2001, and went public on December 26, 2022. It is located at No. 1 Ciji Road, Liangjiang New Area, Chongqing [2]. - The main business involves the research, production, and sales of blood purification equipment, with revenue composition as follows: blood purification equipment 66.12%, blood purification consumables 23.89%, medical services 8.31%, and others 1.68% [2]. Stock Performance - As of September 24, the stock price increased by 2.16% to 14.66 CNY per share, with a total market capitalization of 4.71 billion CNY [1]. - Year-to-date, the stock price has risen by 32.55%, but it has seen a decline of 2.66% over the last five trading days and 5.84% over the last 20 days [2]. Financial Performance - For the first half of 2025, the company achieved a revenue of 357 million CNY, representing a year-on-year growth of 28.72%. The net profit attributable to the parent company was 55.04 million CNY, up by 20.28% year-on-year [2]. - Since its A-share listing, the company has distributed a total of 104 million CNY in dividends [3]. Shareholder Information - As of June 30, 2025, the number of shareholders increased by 2.67% to 8,150, while the average circulating shares per person decreased by 2.60% to 28,779 shares [2]. - Among the top ten circulating shareholders, Bosera Healthcare Mixed A (050026) is the fifth largest, holding 3.26 million shares, an increase of 746,300 shares from the previous period [3].